share_log

Mangoceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Cohen Jacob D.

Mangoceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Cohen Jacob D.

Mangoceuticals | 4：持股變動聲明-高管 Cohen Jacob D.
美股SEC公告 ·  06/06 05:17

牛牛AI助理已提取核心訊息

Jacob D. Cohen, the Chief Executive Officer of Mangoceuticals, Inc. (MGRX), completed a significant stock transaction on June 3, 2024. Cohen was granted 800,000 shares of common stock at no cost, as per the transaction details released. Following this grant, Cohen directly holds a total of 800,000 shares in the company. The transaction, which was classified as a grant, indicates a strengthening of the CEO's stake in Mangoceuticals, potentially signaling confidence in the company's future prospects.
Jacob D. Cohen, the Chief Executive Officer of Mangoceuticals, Inc. (MGRX), completed a significant stock transaction on June 3, 2024. Cohen was granted 800,000 shares of common stock at no cost, as per the transaction details released. Following this grant, Cohen directly holds a total of 800,000 shares in the company. The transaction, which was classified as a grant, indicates a strengthening of the CEO's stake in Mangoceuticals, potentially signaling confidence in the company's future prospects.
Mangoceuticals公司的執行長Jacob D. Cohen於2024年6月3日完成了一筆重要的股票交易。根據發布的交易詳細資料顯示，Cohen被授予了80萬股普通股而不需要付出任何成本。在此授予之後，Cohen直接持有該公司的總股數為80萬股。此次被歸類為授予的交易表明了該公司對於Cohen加強其在Mangoceuticals公司的持股，可能預示著對公司未來前景的信懇智能。
Mangoceuticals公司的執行長Jacob D. Cohen於2024年6月3日完成了一筆重要的股票交易。根據發布的交易詳細資料顯示，Cohen被授予了80萬股普通股而不需要付出任何成本。在此授予之後，Cohen直接持有該公司的總股數為80萬股。此次被歸類為授予的交易表明了該公司對於Cohen加強其在Mangoceuticals公司的持股，可能預示著對公司未來前景的信懇智能。
有用
沒用

該公告為獨立文件：

獨立文件1  查看翻譯

譯文內容由第三人軟體翻譯。


牛牛AI助手部分由第三方人工智慧模型基於資訊內容自動產生，只对除中国内地以外的地区提供。


以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
    熱議
    美股
    股票代碼最新價升跌幅

    暫無數據

    資訊熱榜
    更新時間